Thema: Which

Zealand, Pharma-

Zealand Pharma- vs. Amgen-Aktie: Peptid-Pionier fordert Pharma-Koloss

Zealand Pharma- vs. Amgen-Aktie: Peptid-Pionier fordert Pharma-Koloss - Foto: über boerse-global.de
Zealand Pharma- vs. Amgen-Aktie: Peptid-Pionier fordert Pharma-Koloss - Foto: über boerse-global.de

In the race for next-generation obesity therapies, Amgen's long-acting MariTide challenges Zealand Pharma's multi-asset peptide pipeline. Which strategy leads in 2026?

boerse-global.de, 01.03.26 08:44 Uhr